AbbeyMoor updates Spanner stent design
This article was originally published in The Gray Sheet
Executive Summary
FDA grants supplemental PMA approval for design changes to the prostatic stent aimed at increasing flexibility and patient comfort, AbbeyMoor Medical announces July 6. Spanner, a temporary stent that aids men experiencing difficulty urinating due to prostatic obstruction, received PMA approval in 2006. The device is marketed as an alternative to indwelling catheterization, intermittent catheterization or the use of a suprapubic tube